J. Barrera

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
José M Barrera, Josep M. Barrera, J M Barrera, José María Barrera, Josep M Barrera, José M. Barrera, Joseph M. Barrera, Josep‐maria Barrera, Jose M. Barrera, Jose M Barrera, J. M. Barrera, Josep María Barrera, Josep Marí Barrera, Josep Maria Barrera
Publication record
42 papers · 1,649 citations · H-index 17

PAPERS

The Ediacaran-Cambrian Radiation of Animals within the Villuercas-Ibores-Jara UNESCO Global Geopark, Spain
20210 citationsauthor #4
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4.
20139 citationsauthor #13
Admission hematocrit and transfusion requirements after trauma.
201330 citationsauthor #7
Venous thromboembolism after trauma: A never event?*
201261 citationsauthor #5
748 LACK OF SUSTAINED VIROLOGICAL RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C IS ASSOCIATED WITH A SIGNIFICANT RISK OF PROGRESSION TO CIRRHOSIS
20080 citationsauthor #5
Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study.
200822 citationsauthor #6
[Hypertransaminasemia greater than 400 U/l in adults seen at a tertiary hospital. Prospective study of etiology].
20057 citationsauthor #2
[Use of complementary and alternative medicine in patients with chronic hepatitis C].
200428 citationsauthor #2
[Efficacy of an intervention to improve treatment compliance in hyperlipidemias].
200413 citationsauthor #9
1004 A simple model can predict response to interferon-ribavirin in genotype 1 chronic hepatitis C
20030 citationsauthor #3
[Kidney transplantation in patients positive for hepatitis C virus].
20020 citationsauthor #4
[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study].
20025 citationsauthor #4
High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV‐1b–related cirrhosis
200153 citationsauthor #8
Induction interferon alfa-2a might improve the outcome of compensated hepatitis C virus (HCV)-related cirrhosis
20010 citationsauthor #4
Unusual amino acid heterogeneity within the HCV-1b NS5a region for patients with hepatocellular carcinoma
20001 citationsauthor #6
Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment.
200012 citationsauthor #3
Diagnostic tests for hepatitis C virus infection.
20008 citationsauthor #1
Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
1999109 citationsauthor #13
Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method
199667 citationsauthor #2
[The efficacy of excluding anti-HVC-positive donors by ELISA 2 in the prevention of posttransfusion hepatitis].
19961 citationsauthor #1
Persistent hepatitis C viremia after acute self‐limiting posttransfusion hepatitis C
1995200 citationsauthor #1
Improved Detection of Anti‐HCV in Post‐Transfusion Hepatitis by a Third‐Generation ELISA
1995196 citationsauthor #1
Earlier Detection of anti-HCV Seroconversion in Post-Transfusion NANBH by a Prototype HCV 3.0 ELISA
19943 citationsauthor #1
Mother-to-Infant Transmission of Hepatitis C Virus A Prospective Study
199410 citationsauthor #9
[Retrovirus and blood transfusion].
19930 citationsauthor #1
Is hepatitis C virus infection a trigger of porphyria cutanea tarda?
1993191 citationsauthor #5
Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
199227 citationsauthor #1
Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel.
1992105 citationsauthor #4
Are hepatitis C virus antibodies involved in chronic liver diseases other than non‐A, non‐B hepatitis?
19911 citationsauthor #6
Perinatal transmission of HCV documented by specific PCR in a prospective study
19912 citationsauthor #10
Hepatitis C virus infection among kidney transplant recipients.
199178 citationsauthor #4
Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
199138 citationsauthor #3
Does anti-HBc alone increase the risk for hepato-cellular carcinoma in anti-HCV positive cirrhosis?
19910 citationsauthor #5
Incidence of Non-A, Non-B Hepatitis after Screening Blood Donors for Antibodies to Hepatitis C Virus and Surrogate Markers
199127 citationsauthor #1
Simultaneous hepatitis B and C following transfusion
19900 citationsauthor #1
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.
19900 citationsauthor #2
Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury
1990230 citationsauthor #2
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.
1990103 citationsauthor #2
Antibodies to hepatitis C (anti_HCV) in postransfusion hepatitis
19900 citationsauthor #1
[Post-transfusional hepatitis following cardiac surgery. Incidence, clinical aspects and prognosis].
19873 citationsauthor #1
Influence of HBV replication and delta agent superinfection on T cell subsets and killer (Leu 7+) in chronic hepatitis B virus infection.
198610 citationsauthor #2
[Infection by hepatitis virus in inmates and personnel of a penal institution].
19850 citationsauthor #2

TIMELINE

1985 0 citations

1986 10 citations

1987 3 citations

1990 333 citations

1991 146 citations

1992 132 citations

1993 191 citations

1994 13 citations

1995 396 citations

1996 68 citations

1999 109 citations

2000 21 citations

2001 53 citations

2002 5 citations

2003 0 citations

2004 41 citations

2005 7 citations

2008 22 citations

2012 61 citations

2013 39 citations

2021 0 citations

J. Barrera

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT